Caption Management, LLC Clovis Oncology, Inc. Transaction History

Caption Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.63 - $2.96 $114,946 - $540,066	182,455 New	182,455 $328,000
Q1 2021 May 17, 2021	SELL	$4.81 - $10.34 $103,895 - $223,344	-21,600 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.13 - $6.41 $26,019 - $40,383	6,300 Added 41.18%	21,600 $103,000
Q3 2020 Nov 16, 2020	SELL	$4.82 - $7.72 $203,404 - $325,784	-42,200 Reduced 73.39%	15,300 $88,000
Q2 2020 Aug 14, 2020	BUY	$5.69 - $9.69 $191,753 - $326,553	33,700 Added 141.6%	57,500 $388,000
Q1 2020 May 15, 2020	SELL	$3.77 - $11.0 $136,474 - $398,200	-36,200 Reduced 60.33%	23,800 $151,000
Q2 2019 Aug 13, 2019	BUY	$12.81 - $25.67 $768,600 - $1.54 Million	60,000 New	60,000 $892,000
Q4 2018 Jan 30, 2019	SELL	$11.63 - $32.67 $191,895 - $539,055	-16,500 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$29.37 - $49.48 $484,605 - $816,420	16,500 New	16,500 $484,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.